To define the prevalence of NANB hepatitis, anti-HCV antibodies were determined in 51 patients on renal replacement therapy, in 7 transplanted patients and 17 staffmembers of the hemodialysis unit.
Anti-HCV antibodies were evaluated using immunoenzymatic methods (Ortho HCV ELISA Test System, 1st and 2nd generation).
Among hemodialysis patients, seroconversion was respectively documented in 17.6% (9/51) and 52.9% (27/51); none of the transplanted patients were positive with the 1st generation test, while 3/7 were positive with the 2nd.
Mots-clés Pascal : Hémodialyse, Epuration extrarénale, Réanimation, Appareil urinaire pathologie, Homme, Prévalence, Anticorps, Virus hépatite C, Virus, Technique ELISA, Epidémiologie
Mots-clés Pascal anglais : Hemodialysis, Extrarenal dialysis, Resuscitation, Urinary system disease, Human, Prevalence, Antibody, Hepatitis C virus, Virus, ELISA assay, Epidemiology
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 92-0392085
Code Inist : 002B27B03. Création : 199406.